Back to mobile site

More on SYRE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Spyre Therapeutics (NQ:SYRE)
Delayed: 100.32 +11.98 (13.56%)
Prev. Close $88.34  
Open$95.00 
52 Wk High$ 
52 Wk Low$ 
Day High$101.71 
Day Low$95.00 
P/E N/A  
EPS$ 
Volume2,804,957 

Friends, Peers and Foes (?): ABVX ORKA (more...)

Jun 22, 2026 04:45 PM Form 144 Spyre Therapeutics, Inc. Filed by: HENDERSON MICHAEL THOMAS
Jun 18, 2026 04:00 PM Guggenheim says buy this biotech stock
Jun 16, 2026 07:40 AM Spyre (SYRE) PT Raised to $104 at Jones Trading
Jun 15, 2026 08:02 AM Form 8-K Spyre Therapeutics, Inc. For: Jun 15
Jun 15, 2026 08:01 AM Spyre reports positive phase 2 trial results for ulcerative colitis drug
Jun 15, 2026 08:00 AM Spyre Announces Potential Best-in-Class SPY002 (anti-TL1A) Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients
Jun 5, 2026 04:01 PM Spyre Therapeutics Announces Grants of Inducement Awards
Jun 4, 2026 04:10 AM Spyre (SYRE) PT Raised to $115 at Deutsche Bank
Jun 3, 2026 09:32 PM Form 4 Spyre Therapeutics, Inc. For: Jun 03 Filed by: Sloan Sheldon
Jun 3, 2026 09:31 PM Form 4 Spyre Therapeutics, Inc. For: Jun 01 Filed by: Turtle Cameron
View All Articles

Entities mentioned with SYRE

View All Entities